These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 19593853)

  • 1. Prostate-cancer screening.
    Izmirlian G
    N Engl J Med; 2009 Jul; 361(2):204; author reply 205-6. PubMed ID: 19593853
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostate-cancer screening.
    Catalona WJ
    N Engl J Med; 2009 Jul; 361(2):202; author reply 204-5. PubMed ID: 19587348
    [No Abstract]   [Full Text] [Related]  

  • 3. Screening for prostate cancer--the controversy that refuses to die.
    Barry MJ
    N Engl J Med; 2009 Mar; 360(13):1351-4. PubMed ID: 19297564
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial comment on: Is prostate-specific antigen velocity selective for clinically significant prostate cancer in screening? European Randomized Study of Screening for Prostate Cancer (Rotterdam).
    Terris MK
    Eur Urol; 2009 Feb; 55(2):392; discussion 393. PubMed ID: 18353530
    [No Abstract]   [Full Text] [Related]  

  • 5. Rural residence and prostate cancer screening with prostate-specific antigen.
    Stamatiou K; Skolarikos A
    Rural Remote Health; 2009; 9(2):1227. PubMed ID: 19594290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate-specific antigen and prostate cancer prognosis.
    Church TR
    J Natl Cancer Inst; 2006 Nov; 98(21):1509-10. PubMed ID: 17077347
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prostate-specific antigen--the most important cancer marker. Diagnostics and follow up of prostatic cancer have changed].
    Bratt O; Björk T
    Lakartidningen; 2007 Nov 14-20; 104(46):3460-4. PubMed ID: 18072615
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostate specific antigen screening.
    Block KI
    Integr Cancer Ther; 2009 Jun; 8(2):111-2. PubMed ID: 19679618
    [No Abstract]   [Full Text] [Related]  

  • 9. Prostate cancer screening--is the controversy resolved?
    Norcross WA; Ganiats TG
    West J Med; 1995 Jul; 163(1):65-6. PubMed ID: 7545340
    [No Abstract]   [Full Text] [Related]  

  • 10. [PSA based screening for prostatic cancer].
    Johansen TE
    Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2612-4. PubMed ID: 19023357
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostate-cancer screening.
    Cooperberg MR; Carroll PR
    N Engl J Med; 2009 Jul; 361(2):203; author reply 204-5. PubMed ID: 19593852
    [No Abstract]   [Full Text] [Related]  

  • 12. Japanese Urological Association guidelines on prostate-specific antigen-based screening for prostate cancer and the ongoing cluster cohort study in Japan.
    Ito K; Kakehi Y; Naito S; Okuyama A;
    Int J Urol; 2008 Sep; 15(9):763-8. PubMed ID: 18786203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate-cancer screening.
    Dubben HH
    N Engl J Med; 2009 Jul; 361(2):204; author reply 204-6. PubMed ID: 19593854
    [No Abstract]   [Full Text] [Related]  

  • 14. Weighing the benefits and downsides of prostate-specific antigen screening.
    Pignone M
    Arch Intern Med; 2009 Sep; 169(17):1554-6. PubMed ID: 19786672
    [No Abstract]   [Full Text] [Related]  

  • 15. The jury is still out with regard to screening for the prostate cancer with prostate-specific antigen.
    Eur J Cancer Care (Engl); 2002 Jun; 11(2):78. PubMed ID: 12168606
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prostatic cancer screening].
    Brasso K; Iversen P
    Ugeskr Laeger; 2002 Jan; 164(2):155-7. PubMed ID: 11831076
    [No Abstract]   [Full Text] [Related]  

  • 17. Controversy over prostate-specific antigen screening has shifted from mortality to overtreatment issues.
    Ito K
    Int J Urol; 2009 Sep; 16(9):711-12. PubMed ID: 19777638
    [No Abstract]   [Full Text] [Related]  

  • 18. Upcoming evidences on prostate-specific antigen-based screening for men at risk of prostate cancer.
    Boscolo-Berto R
    Int J Urol; 2009 Sep; 16(9):711. PubMed ID: 19769655
    [No Abstract]   [Full Text] [Related]  

  • 19. [Mass screening for prostate cancer will have to wait. The scientific basis insufficient, more efficient markers necessary].
    Damber JE
    Lakartidningen; 2003 Sep; 100(38):2916-8, 2921. PubMed ID: 14558209
    [No Abstract]   [Full Text] [Related]  

  • 20. The long-awaited drop in prostate cancer mortality: what does it mean?
    Levy IG
    Cancer Prev Control; 1998 Aug; 2(4):159. PubMed ID: 10093626
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.